Real-time head motion monitoring for all MRI scans in older adults at risk for Alzheimer’s disease
Official title: Real-time head motion monitoring for all clinical MR sequences using Universal FIRMM
Funded at Turing Medical Technologies INC · NIH-11536530 · Data updated 2026-11-12
A new technology helps reduce patient movement during MRI scans, especially for people 65 and older who are being pre-screened for Alzheimer’s therapies.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Turing Medical Technologies INC NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | September 22, 2025 |
| Project end | September 21, 2029 |
| Funding year | 2026 |
| Award (this year) | $1,245,404 |
| NIH project number | 4R44AG097349-02 |
| Project ID | NIH-11536530 on NIH RePORTER |
Who could benefit from this research
✓Could help
Older adults being screened or monitored for Alzheimer’s disease therapies who undergo MRI scans.
✕Less likely to help
Patients with MRI scans not affected by motion issues or without upcoming ARIA surveillance may see little direct benefit.
What this research studies
This project aims to prevent blurry or unusable MRI images by real-time motion tracking that works across all MRI sequences. It builds on the existing FIRMM system and adds a universal, RF-based motion-tracking approach so motion can be detected and corrected during the scan. The focus is on ARIA screening and surveillance in Alzheimer’s disease patients, with the goal of improving image quality, reducing the need for repeat scans, and lowering costs and patient burden. The work is intended for widespread clinical use in the US and Europe, potentially streamlining MRI workflows for high-volume pre-screening programs.
Why it matters
Potential benefit: If successful, this technology could lead to more reliable MRI results, faster screenings for Alzheimer’s therapies, and fewer scans requiring repetition.
How similar studies have gone: Previous FIRMM approaches reduced motion impact in MRI, suggesting this universal version could extend those benefits to more MRI protocols.
Where this research is happening
-
Turing Medical Technologies INC
Saint Louis, United States Active
Researchers
- Principal investigator: King, Kevin — Turing Medical Technologies INC
- Study coordinator: King, Kevin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.